Sex-based Approach for the Clinical Impact of the Increased Hemoglobin on Incident AF in the General Population

다국어 초록 (Multilingual Abstract)

Background and Objectives: Although the adverse cardiovascular effect of anemia has been well described, the effect of polycythemia on the incident atrial fibrillation (AF) remain unclear. The objective of this study is to identify the association between increased hemoglobin and incident AF.
Methods: This was a retrospective-cohort study with 434,269 subjects who underwent national health examinations from the Korean National Sample Cohort. We estimated the risk of incident AF according to hemoglobin-based four-categories.
Results: During 3.9-year of follow-up, polycythemia group showed higher incidences of AF (hazard ratio[HR] with 95% confidence interval[CI], 1.50 [1.28–1.76] and 1.69 [1.13–2.56]; in men and women, respectively) than normal hemoglobin group (each p<0.001). In the normal hemoglobin and polycythemia groups, a 1 g/dL increase in hemoglobin level was associated with increased risks of incident AF (1.12 [1.07–1.17] and 1.18 [1.10–1.26] in men and women, each p<0.001). To investigate the specific hemoglobin concentration related to greater AF incidence, we analyzed the sensitivity/specificity of different hemoglobin levels: ≥16.0 g/dL in men and ≥14.5 g/dL in women showed the highest Youden's index, with c-indices of 0.83 and 0.82, respectively. Kaplan-Meier cumulative-event curves according to these specific hemoglobin levels (≥16.0 g/dL in men and ≥14.5 g/dL in women) also showed consistent results in both sexes (each p<0.05).
Conclusions: Even in the Korean general population, increased hemoglobin was significantly associated with higher rate of incident AF. Especially, subjects with hemoglobin levels ≥14.5 g/dL in women and ≥16.0 g/dL among men were associated with increased risk of incident AF.

참고문헌 (Reference)

1 Li H, "The relationship between red blood cell distribution width and atrial fibrillation in Asian population : a cross-sectional study" 42 : 1197-1203, 2019

2 von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE)statement : guidelines for reporting observational studies" 147 : 573-577, 2007

3 Mehmet Serkan Cetin, "The Association between Whole Blood Viscosity and Coronary Collateral Circulation in Patients with Chronic Total Occlusion" 대한심장학회 46 (46): 784-790, 2016

4 Kameneva MV, "Rheologic dissimilarities in female and male blood : potential link to development of cardiovascular diseases" 530 : 689-696, 2003

5 Diamond PT, "Relationship of initial hematocrit level to discharge destination and resource utilization after ischemic stroke : a pilot study" 84 : 964-967, 2003

6 Kim BG, "Relation of preprocedural hemoglobin level to outcomes after percutaneous coronary intervention" 124 : 1319-1326, 2019

7 Langille BL, "Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent" 231 : 405-407, 1986

8 Lippi G, "Red blood cell distribution width : a marker of anisocytosis potentially associated with atrial fibrillation" 11 : 292-304, 2019

9 Ku DN, "Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress" 5 : 293-302, 1985

10 McKechnie RS, "Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention" 110 : 271-277, 2004

11 Gotsadze M, "Monitoring of hemorheological parameters in patients with atrial fibrillation(initial data)"

12 Salazar Vázquez BY, "Lowering of blood pressure by increasing hematocrit with non nitric oxide scavenging red blood cells" 38 : 135-142, 2008

13 Kim IS, "Long-term fine particulate matter exposure and cardiovascular mortality in the general population : a nationwide cohort study" 75 : 549-558, 2020

14 Fukumoto Y, "Localized elevation of shear stress is related to coronary plaque rupture : a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution" 51 : 645-650, 2008

15 Sullivan JL, "Iron and the sex difference in heart disease risk" 1 : 1293-1294, 1981

16 Youden WJ, "Index for rating diagnostic tests" 3 : 32-35, 1950

17 Lim WH, "Impact of hemoglobin levels and their dynamic changes on the risk of atrial fibrillation : a nationwide population-based study" 10 : 6762-, 2020

18 Wolters FJ, "Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI" 93 : e917-26, 2019

19 Malek AM, "Hemodynamic shear stress and its role in atherosclerosis" 282 : 2035-2042, 1999

20 Kunnas T, "Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up" 49 : 45-47, 2009

21 Gotoh S, "Hematocrit and the risk of cardiovascular disease in a Japanese community : the Hisayama study" 242 : 199-204, 2015

22 World Health Organization, "Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity" World Health Organization 2011

23 Liu L, "Fisetin alleviates atrial inflammation, remodeling, and vulnerability to atrial fibrillation after myocardial infarction" 60 : 1398-1406, 2019

24 Lee J, "Cohort profile : The National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea" 46 : e15-, 2017

25 Kim M, "Clinical relationship between anemia and atrial fibrillation recurrence after catheter ablation without genetic background" 27 : 100507-, 2020

26 Holsworth RE Jr, "Cardiovascular benefits of phlebotomy : relationship to changes in hemorheological variables" 29 : 102-116, 2014

27 WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies" 363 : 157-163, 2004

28 Chao TF, "Age threshold for increased stroke risk among patients with atrial fibrillation : a nationwide cohort study from Taiwan" 66 : 1339-1347, 2015

29 Levey AS, "A new equation to estimate glomerular filtration rate" 150 : 604-612, 2009

30 Ponikowski P, "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC" 37 : 2129-2200, 2016